Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In postmenopausal women, IGT (HR: 2.59), hypertension (HR: 3.91), lower HDL−C (HR: 0.96), lower vitamin D (HR: 0.93), and reduced eGFR (HR: 0.97) were independently associated with T2DM.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Prediabetes was defined according to ADA criteria and women were classified as premenopausal (< 51 years), early postmenopausal (51 to 60 years), or late postmenopausal (> 60 years).
Source: Abstract.
This is a retrospective cohort study including 444 women with a clinical history of impaired fasting glucose (IFG; plasma glucose 100 to 126 mg/dL) after evaluation in the Endocrinology outpatient clinic at Fundacion Jimenez Diaz Hospital, between January 2013 and December 2018.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Identification of risk factors for type 2 diabetes across age-based proxies of early and late postmenopausal stages in prediabetic women
Cohort study · Frontiers in Endocrinology · 2026
Original publication title
Identification of risk factors for type 2 diabetes across age-based proxies of early and late postmenopausal stages in prediabetic women
Copyright © 2026 Lizarzaburu-Robles, Mahíllo-Fernández, Paniagua, Ortega Juaristi, Timón, Martínez-Albaladejo, Mas-Fontao, Vázquez and Lorenzo.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Prediabetes is increasingly prevalent, and women transitioning through menopause may face a particularly elevated risk of progressing to type 2 diabetes (T2DM). Estrogen deficiency promotes adiposity, insulin resistance, and inflammation, potentially amplifying the metabolic burden of aging. However, the determinants of T2DM in these women remain insufficiently characterized.
Source: BackgroundAbstract: What methods does the paper describe?
This retrospective study included 229 prediabetic women evaluated at a tertiary-care hospital and followed for up to 5.5 years. Prediabetes was defined according to ADA criteria and women were classified as premenopausal (< 51 years), early postmenopausal (51 to 60 years), or late postmenopausal (> 60 years). Clinical and biochemical variables were analyzed for hazard ratios (HR) of T2DM using Cox regression, and Kaplan-Meier curves.
Source: MethodsAbstract: Results
During follow−up, 18% of premenopausal and 35% of postmenopausal women developed T2DM. Higher BMI predicted T2DM in both groups. In postmenopausal women, IGT (HR: 2.59), hypertension (HR: 3.91), lower HDL−C (HR: 0.96), lower vitamin D (HR: 0.93), and reduced eGFR (HR: 0.97) were independently associated with T2DM. Stratification revealed that early post-menopause carried the highest incidence of T2DM. In early post-menopause, higher BMI and uric acid, and lower vitamin D were independent predictors, whereas in late post-menopause, hypertension and reduced eGFR were the strongest determinants.
Source: ResultsAbstract: Conclusions
Risk Factors associated with progression to T2DM in prediabetic women appear to differ across age-defined menopausal stages. Excess adiposity remains a key factor, whereas early post-menopause is characterized by additional associations with hyperuricemia and vitamin D deficiency. In late post-menopause, hypertension and declining renal function appear to be more prominent. These findings support stage-specific risk assessment and tailored preventive strategies in prediabetic women.
Source: ConclusionsAuthors’ abstract
Background
Prediabetes is increasingly prevalent, and women transitioning through menopause may face a particularly elevated risk of progressing to type 2 diabetes (T2DM). Estrogen deficiency promotes adiposity, insulin resistance, and inflammation, potentially amplifying the metabolic burden of aging. However, the determinants of T2DM in these women remain insufficiently characterized.
Methods
This retrospective study included 229 prediabetic women evaluated at a tertiary-care hospital and followed for up to 5.5 years. Prediabetes was defined according to ADA criteria and women were classified as premenopausal (< 51 years), early postmenopausal (51 to 60 years), or late postmenopausal (> 60 years). Clinical and biochemical variables were analyzed for hazard ratios (HR) of T2DM using Cox regression, and Kaplan-Meier curves.
Results
During follow−up, 18% of premenopausal and 35% of postmenopausal women developed T2DM. Higher BMI predicted T2DM in both groups. In postmenopausal women, IGT (HR: 2.59), hypertension (HR: 3.91), lower HDL−C (HR: 0.96), lower vitamin D (HR: 0.93), and reduced eGFR (HR: 0.97) were independently associated with T2DM. Stratification revealed that early post-menopause carried the highest incidence of T2DM. In early post-menopause, higher BMI and uric acid, and lower vitamin D were independent predictors, whereas in late post-menopause, hypertension and reduced eGFR were the strongest determinants.
Conclusions
Risk Factors associated with progression to T2DM in prediabetic women appear to differ across age-defined menopausal stages. Excess adiposity remains a key factor, whereas early post-menopause is characterized by additional associations with hyperuricemia and vitamin D deficiency. In late post-menopause, hypertension and declining renal function appear to be more prominent. These findings support stage-specific risk assessment and tailored preventive strategies in prediabetic women.
Publication and source details
Original title: Identification of risk factors for type 2 diabetes across age-based proxies of early and late postmenopausal stages in prediabetic women
Juan Carlos Lizarzaburu-Robles; Ignacio Mahíllo-Fernández; Amalia Paniagua; Maite Ortega Juaristi; Blanca Timón; Sacramento Martínez-Albaladejo; Sebastián Mas-Fontao; Clotilde Vázquez; Oscar Lorenzo
Frontiers in Endocrinology · 2026
* Correspondence: Juan Carlos Lizarzaburu-Robles, juan.lizarzaburu@estudiante.uam.es; Oscar Lorenzo, olorenzo@fjd.esCopyright © 2026 Lizarzaburu-Robles, Mahíllo-Fernández, Paniagua, Ortega Juaristi, Timón, Martínez-Albaladejo, Mas-Fontao, Vázquez and Lorenzo.2026Lizarzaburu-Robles, Mahíllo-Fernández, Paniagua, Ortega Juaristi, Timón, Martínez-Albaladejo, Mas-Fontao, Vázquez and Lorenzohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:40:45.918319+00:00
DOI: 10.3389/fendo.2026.1891487 · PMC13619503